All Stories

Takeda fronts $46M for 2nd small molecule collab with BridGene

Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology.

Feb 25, 2025 - 14:11
 0
Takeda fronts $46M for 2nd small molecule collab with BridGene
Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology.
Read More

Tags:

Previous Article

Repare unveils scale of layoffs with 75% of staff and chief medical officer head...

Next Article

‘Fear and uncertainty’: Biotech investors warn of impact from NIH research cuts

Related Posts

Gilead loses interest in Arcus’ kidney cancer rival to Merck's Welireg

Gilead loses interest in Arcus’ kidney cancer rival to ...

Feb 18, 2025  0

CMR Surgical nets $200M to support Versius robot’s US launch

CMR Surgical nets $200M to support Versius robot’s US l...

Apr 2, 2025  0

Abbott secures European approval for Volt pulsed field ablation system

Abbott secures European approval for Volt pulsed field ...

Mar 27, 2025  0